About Endonovo Therapeutics, Inc.

Endonovo Therapeutics, Inc. engages in developing off bio-electronic approach to regenerative medicine. It focuses on rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. The company was founded on May 26, 2011 and is headquartered in Woodland Hills, CA.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -20.00$ per share.

The book value per share is -17.80$

Endonovo Therapeutics, Inc. website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- 73.40% -4M - -10M -20.00 - - 1M -17.80 -3M - -3M